While adopting NAT assays greatly shorten the window period that allows detection of many serologically undetectable infections possible, donations with MP-reactive but ID-non-reactive donations (MP+/ID−, defined as non-resolved donations) have been observed during daily screening process. Here, BRD2 is linked to infection.